← Leaderboards
Renata Jaskula-Sztul
University Of Alabama At Birmingham
$501,522
Attributed
$1,124,472
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $581.3K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$1,124,472 · 3
By mechanism
R21$1,124,472 · 3
Top collaborators
- Xiaoguang Margaret Liu4 shared
- Sadanandan E. Velu2 shared
- Suzanne Elizabeth Lapi1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Maria B Grant$24,532,308
- Charles J Frazier$5,884,504
- Trygve O Tollefsbol$6,204,552
- Xiaoguang Margaret Liu$3,757,363
- Michael Edwin Boulton$9,864,814
Others in their field
Other Emerging Leaders on “Targeted Treatment”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$66,755,704
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
Targeted TreatmentIn VivoPharmaceutical PreparationsDoseBiodistributionIn VitroIslet Cell TumorPancreasTumor Cell LineWestern BlottingSomatostatin ReceptorOverexpressionCell ProliferationAntibodiesHormone SecretionApoptosisCell MembraneExcisionIncidenceDesignCytotoxic AgentAnti-CancerAntitumor ResponseCancer Cell
Grant awards (5)
Targeted neuroendocrine cancer therapy using Verrucarin A$170,089
R21 · FY2023 · CA · contact PI
Targeted neuroendocrine cancer therapy using Verrucarin A$208,271
R21 · FY2022 · CA · contact PI
Somatostatin receptor 2 (SSTR2) antibody-drug conjugate for pancreatic neuroendocrine tumor (PanNET) therapy$164,785
R21 · FY2021 · CA · contact PI
Imaging of alterations in SSTR2 expression with histone deacetylase (HDAC) inhibitors treatment for neuroendocrine tumors$381,830
R21 · FY2020 · CA · contact PI
Somatostatin receptor 2 (SSTR2) antibody-drug conjugate for pancreatic neuroendocrine tumor (PanNET) therapy$199,497
R21 · FY2020 · CA · contact PI